Cargando…
Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer
BACKGROUND: Accurate assessment of a patient’s risk of recurrence and treatment response is an important prerequisite of personalized therapy in lung cancer. This study extends a previously described non-small cell lung cancer prognostic model by the addition of chemotherapy and co-morbidities throu...
Autores principales: | Putila, Joseph, Guo, Nancy Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072724/ https://www.ncbi.nlm.nih.gov/pubmed/24967586 http://dx.doi.org/10.1371/journal.pone.0100994 |
Ejemplares similares
-
Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study
por: Putila, Joseph, et al.
Publicado: (2011) -
Correction: Combining Clinical, Pathological, and Demographic Factors Refines Prognosis of Lung Cancer: A Population-Based Study
por: Putila, Joseph, et al.
Publicado: (2011) -
Association of Arsenic Exposure with Lung Cancer Incidence Rates in the United States
por: Putila, Joseph J., et al.
Publicado: (2011) -
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data
por: Ye, Qing, et al.
Publicado: (2021) -
Pathological Mechanism and Targeted Drugs of COPD
por: Guo, Peng, et al.
Publicado: (2022)